Trump Plans to Unveil Deal to Reduce Costs for Weight Loss Medications

According to inside sources, President Trump is poised to reveal an accord aimed at decreasing the prices of certain medications for obesity.

The announcement is set to take place on Thursday at 11 in the morning.

The negotiation, involving collaboration with executives from Eli Lilly and Novo Nordisk, is anticipated to bring down the monthly cost of obesity treatments to $149 in specific scenarios, though further details on these situations remain undisclosed.

Eli Lilly has communicated that it is actively engaging with the administration to broaden patient access, secure medicinal advancements, and enhance affordability, although specific information is currently unavailable.

Novo Nordisk commented that it is involved in productive dialogues with the government concerning the Most Favored Nation executive order, maintaining its focus on improving accessibility and cost-effectiveness for patients, with ongoing efforts to discover methods enabling access to essential medications.